The United States has announced a trade agreement with the United Kingdom that eliminates tariffs on pharmaceutical products and medical technologies. In return, the United Kingdom will increase the percentage of the NHS budget allocated to medications and will pay 25% more for new drugs. The agreement aims to stimulate investment and innovation in both countries, according to U.S. Trade Representative Jamieson Greer. A change in the assessment of therapy value by NICE is also expected, which will modify the threshold used to determine the effectiveness of medications. The U.S. has pressured the UK to pay more for American drugs, and the pharmaceutical industry has expressed dissatisfaction with the conditions in the United Kingdom. London has committed to reducing the reimbursement rate to 15% starting in 2026.
Sources
Latest News
20:25
PSD makes administrative reform a condition for approving the 2027 budget / “Taxes for Romanians and Romanian companies will not increase”
20:02
Luca Niculescu: “In the third quarter, Romania recorded the second-highest economic growth in the European Union”
19:47
Moscow threatens London with retaliation in the event of restrictions imposed on Russia during the British presidency of the G20
19:40
Poland’s Central Bank halts payments to the Constitutional Tribunal amid a power struggle between the government and the presidency
19:23
The Senate approved the appointment of Nadia Cerva as secretary of the Permanent Bureau, at the PSD’s proposal
See more news